Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis

被引:0
作者
Castilla, J. [1 ,2 ,3 ]
Martinez-Baz, I. [1 ,2 ,3 ]
Martinez-Artola, V. [4 ]
Fernandez-Alonso, M. [5 ]
Reina, G. [5 ]
Guevara, M. [1 ,2 ,3 ]
Garcia Cenoz, M. [1 ,2 ,3 ]
Elia, F. [6 ]
Alvarez, N. [7 ]
Barricarte, A. [1 ,2 ,3 ]
Ezpeleta, C. [4 ]
机构
[1] Publ Hlth Inst Navarre, Pamplona, Spain
[2] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res, Ctr Epidemiol, Barcelona, Spain
[3] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res, Ctr Publ Hlth, Barcelona, Spain
[4] Hosp Complex Navarre, Pamplona, Spain
[5] Univ Navarra Clin, Pamplona, Spain
[6] Navarre Hlth Serv, Primary Healthcare Directorate, Pamplona, Spain
[7] Navarre Hlth Serv, Pamplona, Spain
来源
EUROSURVEILLANCE | 2013年 / 18卷 / 07期
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We present estimates of influenza vaccine effectiveness (VE) in Navarre, Spain, in the early 2012/13 season, which was dominated by influenza B. In a population-based cohort using electronic records from physicians, the adjusted VE in preventing influenza-like illness was 32% (95% confidence interval (CI): 15 to 46). In a nested test-negative case-control analysis the adjusted VE in preventing laboratory-confirmed influenza was 86% (95% CI: 45 to 96). These results suggest a high protective effect of the vaccine.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 14 条
[1]  
Aguilar I, 2012, EURO SURVEILL, V17
[2]  
[Anonymous], 2012, Wkly Epidemiol Rec, V87, P83
[3]  
[Anonymous], EURO SURVEILL
[4]  
[Anonymous], EURO SURVEILL
[5]  
[Anonymous], EURO SURVEILL
[6]  
[Anonymous], 2013, 52013 I SAL CARL 3
[7]  
European Commission, 2008, OFFICIAL J EUROPEAN, VL 159
[8]  
Instituto de Salud Publica de Navarra, 2012, B INF, V69
[9]   Evidence of bias in estimates of influenza vaccine effectiveness in seniors [J].
Jackson, LA ;
Jackson, ML ;
Nelson, JC ;
Neuzil, KM ;
Weiss, NS .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (02) :337-344
[10]  
Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P32